Hepatic medicine: evidence and research影响因子
WebDepartment of Molecular Medicine and Metabolism, Research Institute of Environmental Medicine, Nagoya University, Nagoya 464-8601, Japan Hisashi Kato Department of Endocrinology, Metabolism and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan Masashi … http://www.nativeee.com/index.php/news/384.html
Hepatic medicine: evidence and research影响因子
Did you know?
WebHepatic Medicine: Evidence and Research 2024, 12:153-172 Published Date: 27 October 2024. Review. Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver … Web1Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition,2Department of Genetics, Cell Biology and Development, University of Minnesota Medical School, Minneapolis, MN 55455, USA Abstract: Cirrhosis is characterized by extensive hepatic fibrosis, and it is the 14th leading cause of death worldwide.
Web21 dec. 2010 · A peer-reviewed, open access journal in hepatology, liver, liver diseases & hepatic disorders. DOAJ is a unique and extensive index of diverse open access … WebAmerican Journal of Biomedical Science & Research provides a unique platform where you can share the original research in supporting the advancement of Science, Technology, Engineering & Medicine and biomedical sciences journals. American Journal of Biomedical Science & Research ISSN: 2642-1747. ISI Impact Factor: 1.628. [email protected].
Web9 aug. 2024 · 那些血液学(HEMATOLOGY)SCI期刊容易发表? 影响因子是衡量期刊水平的重要指标,一般而言,影响因子较高的期刊投稿命中率较低,相对较难中,而影响因子较低的期刊则相对容易发表,为方便大家投稿时选刊,耐特译根据影响因子高低对各个学科期刊进行了排名,供大家投稿时参考。 血液学(HEMATOLOGY)领域SCIE期刊及其影响因子 … WebHepatic Medicine: Evidence and Research 2024, 15:27-32 Published Date: 28 March 2024. Review. COVID-19-Associated Liver Injury. Gildea DT, Woo SM, O'Connor CE, Rangnekar AS. Hepatic Medicine: Evidence and Research 2024, 15:1-9 Published Date: 21 February 2024.
Web13 mei 2024 · Purpose:The introduction of direct-acting antivirals (DAAs) has revolutionized the treatment of chronic hepatitis C viral (HCV) infection. This study aims to establish real-world treatment efficacy of Sofosbuvir-based (SOF-B) and Ombitasvir/Paritaprevir/Ritonavir-based (OPR-B) regimens.
WebMehrotra, S., Lalwani, S., & Nundy, S. (2024). Management Strategies for Patients with Hilar Cholangiocarcinomas: Challenges and Solutions. Hepatic Medicine: Evidence ... cruisers 5000 sedan sportWebThe hepatic stellate cell, which plays a pivotal role in hepatic fibrosis, contains the filament vimentin which is known to undergo protein citrullination and become immunogenic. cruisers 320 express specsWebHepatic Medicine: Evidence and Research的ISSN是 - 。 ISSN 是一个8位数的代码,用于识别各种报纸,期刊,杂志和期刊以及所有媒体 - 包括印刷版和电子版。 Hepatic … build to lease agreement